Afterward, we established a model to predict the prognosis of colon cancer using four oxaliplatin resistance-related genes (ALCAM, CD22, CASP1, and CISH) on the basis of stepwise regression and LASSO Cox regression. This evidence concerns the gene CASP1 and colonic neoplasm.